No papules or pustules were present, but the patient reported a history of
acne that was controlled by topical antibiotics. No other family members were
similarly affected.
Full face resurfacing was performed by means of a high-energy, pulsed CO2
laser (Coherent Ultrapulse, Santa Clara, Calif). Two laser passes were delivered
to the entire face at 300 mJ energy and 60 W power through an 8-mm2
scanning handpiece and # 6 density. Partially desiccated skin was removed with
saline-soaked gauze after each laser pass. Immediately after surgery, the
laser-irradiated skin appeared pale pink without bleeding. Postoperative wound
care included frequent application of Aquaphor ointment (Beiersdorf, Inc,
Norwalk, Conn) and ice packs for the first 72 hours with subsequent gentle
steaming, dilute acetic acid compresses, and BiO2 healing balm (BiO2
Cosmeceuticals, Beverly Hills, Calif) until re-epithelialization was complete (7
days). Significant lesional improvement was apparent 6 months later with
complete loss of the honeycombed skin appearance and reduced erythema and depth
of scarring (Fig 1, B
). These changes were maintained on further follow-up at 12 months.
Case 2
A 31-year-old woman presented with intense erythema of her cheeks and chin,
scattered papules, and numerous well-defined pitted follicular scars in a
reticulate pattern (Fig 2, A).
Fig. 2. Erythema and
pitted follicular scars on cheeks before (A) and 8 weeks after (B)
fourth 585 nm pulsed dye laser treatment (average fluence, 5.5 J/cm2;
10-mm spot). No new papules or scars were observed 1 year after final
treatment session despite cessation of topical therapy.
|
 |
| full
size
view |
The lesions had first been noted 10 years earlier, with progressive worsening
through the years and upon exposure to extreme temperature changes. No other
family member was known to have experienced a similar skin condition. The
patient had received treatment with topical metronidazole resulting in good
control of the papular component of her condition, but without any effect on the
underlying erythema and follicular atrophy.
Because the erythematous aspect of her facial lesions was most pronounced,
vascular-specific 585 nm flashlamp-pumped pulsed dye laser treatments (ScleroPlus,
Candela Laser Corp, Wayland, Mass) were initiated. The chin and cheeks were
treated with adjacent, nonoverlapping 10-mm spots at a fluence of 5.0 J/cm2.
No topical or intralesional anesthetic was used. The laser-irradiated areas
appeared purpuric, without vesiculation or crusting. Postoperative wound care
consisted of daily application of topical antibiotic ointment until the
laser-induced purpura were cleared (5 days). Upon noticeable clinical
improvement with decreased erythema and improved skin texture 8 weeks later, 3
additional pulsed dye laser treatments were subsequently delivered at 8-week
intervals (average fluence, 5.5 J/cm2; 10-mm spot), resulting in
marked lesional clearing (Fig 2, B
). Topical metronidazole was discontinued after initiation of the laser
treatments, and only mild soap and sunscreen-containing moisturizer were used.
The favorable skin changes observed after 4 successive pulsed dye laser sessions
were maintained at 1 year without evidence of new papules or scars.
Atrophoderma vermiculata is characterized by erythema and reticulate atrophic
scarring of the face and is categorized as a follicular syndrome with
inflammation and atrophy. Additional entities of the same group are keratosis
pilaris atrophicans faciei and keratosis follicularis spinulosa decalvans, which
can be distinguished from atrophoderma vermiculata by location, degree of
inflammation, mode of inheritance, and histologic pattern. Each of these
diseases manifests in early infancy and runs a chronic course with only rare
spontaneous regression seen. Their common pathologic features are follicular
dilation, hyperkeratosis, and ultimate follicular destruction. Patients with
atrophoderma vermiculata are often psychologically affected by their obvious
facial lesions and thus are compelled to seek cosmetically effective treatment.
Because there are no causative therapeutic modalities available, palliative
treatment has been attempted with topical steroids, tretinoin creams, and
systemic retinoids. More aggressive treatment modalities include cryotherapy,
dermabrasion, and laser therapy.
In the first case described, the primary cutaneous manifestation was atrophic
scarring. Laser vaporization of atrophic scars with pulsed and scanned CO2
lasers has been shown to improve the clinical appearance of atrophic scars by
providing removal of fibrotic tissue and the opportunity for re-epithelialization
and neocollagenesis.5 In addition,
heat-induced collagen shrinkage is effected with progressive collagen remodeling
over several months, serving to further enhance the clinical effect.6
In the second patient, the predominant clinical feature was intense facial
erythema with follicular accentuation. A vascular-specific 585-nm flashlamp-pumped
pulsed dye laser was thus used to achieve vessel destruction through selective
photothermolysis. In addition, pulsed dye laser irradiation of various
inflammatory and scarred conditions7-10
has been shown to cause a limited degree of collagen remodeling, which could
also account for the favorable and long-standing results obtained in this case.
In conclusion, the two cases of atrophoderma vermiculata described herein
exemplify the variable clinical manifestations and different treatment
approaches that can be applied to cause favorable cosmetic outcomes in patients
in whom limited therapeutic modalities previously existed. Future use of these
and other combination treatments may also serve to enhance results and speed
postoperative recovery.
1. Rozum LT, Mehregan AH, Johnson
SAM. Folliculitis ulerythematosus reticulata: a case with unilateral lesion.
Arch Dermatol 1972;106:388-9.
2. Frosch PJ, Bumage MR, Schuster-Pavlovic
C, et al. Atrophoderma vermiculatum: case reports and review. J Am Acad
Dermatol 1988;18:538-42.
3. Barron DR, Hirsch AL, Buchbinder
L, et al. Folliculitis ulerythematosus reticulata: a report of four cases and
brief review of the literature. Pediatr Dermatol 1987;4:85-9.
4. Ellis JP. Familial atrophoderma
vermiculatum: case report. Br J Dermatol 1980;103:57-8.
5. Alster TS, West TB. Resurfacing
of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser.
Dermatol Surg 1996;22:151-5.
6. Walia S, Alster TS. Prolonged
clinical improvement of atrophic acne scars after CO2 laser
resurfacing. Dermatol Surg 1999;25:926-30.
7. Alster TS. Inflammatory linear
verrucous epidermal nevus: successful treatment with the 585 nm flashlamp-pumped
pulsed dye laser. J Am Acad Dermatol 1994;31:513-4.
8. Alster TS, Wilson F. Focal
dermal hypoplasia (Goltz syndrome): treatment with the 585 nm flashlamp-pumped
pulsed dye laser. Arch Dermatol 1994;31:513-4.
9. Alster TS. Improvement of
erythematous and hypertrophic scars by the 585 nm flashlamp-pumped pulsed dye
laser. Ann Plast Surg 1994;32:186-90.
10. Alster TS, Williams CM.
Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed dye
laser. Lancet 1995;345:1198-200.
- From the Washington Institute of
Dermatologic laser Surgery.
- Reprint requests: Tina S. Alster, MD, 2231
m St, NW, Suite 200, Washington, DC 20037.
- J Am Acad Dermatol 2001;44:693-5
-
Copyright © 2000 by the American Academy of Dermatology, Inc.
Limited Non-Profit Use Granted